TrialAntimicrobial agents and chemotherapy2014

Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.

Jessica Manning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.